Abstract:Background Pathophysiological changes of Huntington's disease (HD) can precede symptom onset by decades. Robust imaging biomarkers are needed to monitor HD progression, especially before the clinical onset. Purpose To investigate iron dysregulation and microstructure alterations in subcortical regions as HD imaging biomarkers, and to associate such alterations with motor and cognitive impairments. Study Type Prospective. Population Fourteen individuals with premanifest HD (38.0 ± 11.0 years, 9 females; far‐from‐onset N = 6, near‐onset N = 8), 21 manifest HD patients (49.1 ± 12.1 years, 11 females), and 33 age‐matched healthy controls (43.9 ± 12.2 years, 17 females). Field Strength/Sequence 7 T, T1‐weighted imaging, quantitative susceptibility mapping, and diffusion tensor imaging. Assessment Volume, susceptibility, fractional anisotropy (FA), and mean diffusivity (MD) within subcortical brain structures were compared across groups, used to establish HD classification models, and correlated to clinical measures and cognitive assessments. Statistical Tests Generalized linear model, multivariate logistic regression, receiver operating characteristics with the area under the curve (AUC), and likelihood ratio test comparing a volumetric model to one that also includes susceptibility and diffusion metrics, Wilcoxon paired signed‐rank test, and Pearson's correlation. A P‐value <0.05 after Benjamini–Hochberg correction was considered statistically significant. Results Significantly higher striatal susceptibility and FA were found in premanifest and manifest HD preceding atrophy, even in far‐from‐onset premanifest HD compared to controls (putamen susceptibility: 0.027 ± 0.022 vs. 0.018 ± 0.013 ppm; FA: 0.358 ± 0.048 vs. 0.313 ± 0.039). The model with additional susceptibility, FA, and MD features showed higher AUC compared to volume features alone when differentiating premanifest HD from HC (0.83 vs. 0.66), and manifest from premanifest HD (0.94 vs. 0.83). Higher striatal susceptibility significantly correlated with cognitive deterioration in HD (executive function: r = −0.600; socioemotional function: r = −0.486). Data Conclusion 7 T MRI revealed iron dysregulation and microstructure alterations with HD progression, which could precede volume loss, provide added value to HD differentiation, and might be associated with cognitive changes. Evidence Level 2 Technical Efficacy Stage 2

Interplay between Sex and Disease Burden in Huntington's Disease: Clinical and Neuroimaging Perspectives

Sex differences in Huntington's disease from a neuroinflammation perspective

Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review

Modifiable factors associated with Huntington's disease progression in presymptomatic participants

Huntington disease: natural history, biomarkers and prospects for therapeutics

Mental health symptoms among those affected by Huntington's disease: A cross-sectional study

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects

Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD study

Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes

Sex-based Disparities in Brain Aging: A Focus on Parkinson's Disease

Factors Influencing the Total Functional Capacity Score as a Critical Endpoint in Huntington's Disease Research

Sex differences in the pleiotropy of hearing difficulty with imaging-derived phenotypes: a brain-wide investigation

Mapping the Order and Pattern of Brain Structural MRI Changes Using Change‐point Analysis in Premanifest Huntington's Disease

Sex influences clinical phenotype in frontotemporal dementia

Linking White Matter and Deep Gray Matter Alterations in Premanifest Huntington Disease.

Clinical and genetic association studies reveal within-individual variability as an integral part of Huntington disease

Systems level analysis of sex-dependent gene expression changes in Parkinson’s disease

The clinical, imaging and biological features of psychosis in Han Chinese patients with Huntington's disease

Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI